Affiliation:
1. Gomel State Medical University
Abstract
Objective. To evaluate the activity of pyruvate kinase (PK) isoforms in normal conditions, in toxic damage of the liver and during its regeneration.Materials and methods. An experimental study was carried out on 45 Wistar rats. Toxic liver damage was induced by the intraperitoneal administration of carbon tetrachloride. Mechanical damage was simulated by the surgical resection of the liver. The levels of PK isoforms R/L and M in the blood serum and liver tissue of the laboratory animals were measured with an ELISA test.Results. It has been found that the level of PK isoform M signifcantly increases in chronic toxic liver damage, which may indicate the activation of the processes of liver cell proliferation in response to the damaging effect of hepatotoxin (Mann-Whitney U Test: Z = 2.143; p = 0.032). After liver resection, the level of PK R/L, which characterizes the activation of glycolysis, increased and the level of pyruvate kinase M increased signifcantly, which reflected the processes of reparative regeneration in the liver.Conclusion. The serum level of PK isoforms may be used as a laboratory criterion for the activity of reparative regeneration processes, which can be used to evaluate the reparative potential of the liver in case of toxic or mechanical damage, as well as in chronic diffuse diseases.
Publisher
Gomel State Medical University
Reference13 articles.
1. Muirhead H. Isoenzymes of pyruvate kinase. Biochem Soc Trans. 1990 Apr;18(2):193-196. DOI: https://doi.org/10.1042/bst0180193
2. Noguchi T, Yamada K, Yamagata K, Takenaka M, Nakajima H, Imai E, et al. Expression of liver type pyruvate kinase in insulinoma cells: involvement of LF-B1 (HNF1). Biochem Biophys Res Commun. 1991 Nov 27;181(1):259-264. DOI: https://doi.org/10.1016/s0006-291x(05)81411-1
3. Valentini G, Chiarelli LR, Fortin R, Dolzan M, Galizzi A, Abraham DJ et al. Structure and function of human erythrocyte pyruvate kinase. Molecular basis of nonspherocytic hemolytic anemia. J Biol Chem. 2002 Jun 28;277(26):23807-23814. DOI: https://doi.org/10.1074/jbc.M202107200
4. Zhang Z, Deng X, Liu Y, Liu Y, Sun L, Chen F. PKM2, function and expression and regulation. Cell Biosci. 2019 Jun 26;9:52. DOI: https://doi.org/10.1186/s13578-019-0317-8
5. Oremek GM, Rutner F, Sapoutzis N, Sauer-Eppel H. Tumor marker pyruvate kinase type tumor M2 in patients suffering from diabetic nephropathy. Anticancer Res. MarApr 2003;23(2A):1155-1158.